Spheres Was Invited to 2021 Nanxiang Precision Medicine International Innovation Competition

On June 30, the 2021 Nanxiang Precision Medicine International Innovation and Entrepreneurship Competition Shanghai Station closed-door roadshow was successfully held. More than fifty investment institutions such as Oriza Seed Fund, Yunfeng Capital, CD Capital, Yuansheng Venture Capital, and GP Healthcare Fund gathered together to communicate face-to-face with participating projects and provide professional guidance and comments for entrepreneurs.

Spheres was invited to the competition as the judge. A total of 15 projects were finally shortlisted for the Shanghai station semi-finals, covering in vitro diagnostics, genetic testing, immunotherapy, medical 3D printing and other precision medicine subdivisions.

At the roadshow site, the contestants showed the technical advantages, application scenarios, development plans, etc. of their respective projects in turn; the investment judges comprehensively considered market competitiveness and commercial investment value, scored the projects on site, and gave corresponding guidance and advisory.

The 2021 Nanxiang Precision Medicine International Innovation and Entrepreneurship Competition aims to integrate various precision medicine innovation and entrepreneurship resources, promote the deep integration of technology, finance, and industry, guide all sectors of the society to support precision medicine innovation and entrepreneurship, and achieve "introduction of intelligence through competition" and "convergence of talents" ", to inject innovation momentum into enterprise development and industrial cultivation.